Apollo Medical Holdings Inc (3AM.MU) Seasonal returns chart
This article provides a seasonal returns chart for Apollo Medical Holdings Inc (3AM.MU), showing its average monthly price return from 2021 to 2026. As of November 16, the stock was trading at 28.80 EUR. The page also includes navigation for various financial data related to the company.
Apollo Medical Holdings Inc (3AM.SG) stock price, news, quote and history
This page provides an overview of Apollo Medical Holdings Inc (3AM.SG) stock, including its current price, news, and historical data. The stock is listed at 47.20 EUR, up 5.36% as of July 23 at 10:00:00 pm GMT+2. The news section highlights recent reports primarily focusing on Astrana Health (ASTH), discussing Q3 2026 earnings, Medicaid coverage, and various partnerships.
Apollo Medical Holdings Inc (3AM.SG) Seasonal returns chart - Yahoo Finance
The article presents a seasonal returns chart for Apollo Medical Holdings Inc (3AM.SG) on Yahoo Finance. It shows the average monthly price return for the stock from 2021 to 2026. The current stock price is reported as 47.20 EUR, up 5.36% as of July 23.
Apollo Medical Holdings Inc (3AM.DU) Seasonal returns chart
This article from Yahoo Finance presents a seasonal returns chart for Apollo Medical Holdings Inc (3AM.DU). It displays the average monthly price return for the company between 2021 and 2026. The article also provides a summary, news, chart, statistics, historical data, profile, financials, analysis, seasonality, options, and holders for the company.
Astrana Health Q3 Earnings Call Highlights
Astrana Health (ASTH) reported record third-quarter revenue of $1.02 billion and adjusted EBITDA of $77.2 million, driven by growth in Medicare Advantage membership and full-risk contracts, despite declines in Medicaid and exchange enrollment. The company maintained its full-year guidance, narrowed ranges, and expects to achieve mid-to-high-teens membership growth in its ACO programs in 2027, with continued confidence in mid-teens annual adjusted EBITDA growth over the medium term. Astrana Health also continued to invest in growth, including new partnerships and a tuck-in acquisition, while making progress on debt repayment and net leverage reduction.
How Apollo Medical Holdings Inc. (ASTH) Affects Rotational Strategy Timing
Apollo Medical Holdings Inc. (NASDAQ: ASTH) is showing strong sentiment across all time horizons, supporting an overweight bias according to AI models. The analysis highlights an exceptional 66.8:1 risk-reward setup, targeting a 19.2% gain against a 0.3% risk. Three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—have been generated to cater to different risk profiles.
Apollo Medical Holdings Inc (3AM.DU) stock price, news, quote and history
Apollo Medical Holdings Inc (3AM.DU) stock closed at 32.60 EUR, down 4.12%, on October 16, 2026. The stock has shown significant year-to-date growth of 55.24% but a 5-year return of -46.99%. Key financial metrics like market cap, P/E ratio, and EPS are currently unavailable, and its next earnings date is set for November 5, 2026.
Apollo Medical Holdings Inc (3AM.DU) stock price, news, quote and history
This article provides detailed financial information for Apollo Medical Holdings Inc (3AM.DU), including its current stock price, historical data, and performance metrics. It shows the company's stock trading at 31.80 EUR, down 3.64%, with year-to-date returns significantly outperforming the S&P 500. The page also features key financial highlights, valuation measures, and upcoming earnings dates.
Astrana Health (ASTH): Buy, Sell, or Hold Post Q2 Earnings?
Astrana Health (ASTH) has seen a significant 35.1% return over the past six months, outperforming the S&P 500. The company, formerly Apollo Medical Holdings, exhibits strong momentum with a 40.2% compounded annual sales growth and 11.6% compounded annual EPS growth over five years. However, its return on invested capital (ROIC) has declined, raising a point of caution, though positive characteristics are seen to outweigh the negatives, with the stock trading at 11.1x forward P/E.
Astrana Health (ASTH): Buy, Sell, or Hold Post Q2 Earnings?
Astrana Health (ASTH), formerly Apollo Medical Holdings, has seen its stock price climb significantly, outperforming the S&P 500. The company boasts strong revenue growth and outstanding long-term EPS growth, indicating its success in value-based payment models and resonating offerings. However, a declining return on invested capital (ROIC) suggests that recent investments have yet to yield positive returns, prompting investors to consider whether its current valuation is justified.
Precision Trading with Apollo Medical Holdings Inc. (ASTH) Risk Zones
Stock Traders Daily provides a detailed analysis of Apollo Medical Holdings Inc. (ASTH), highlighting divergent sentiment across all horizons and a mid-channel oscillation pattern. The report outlines three distinct trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones, alongside a multi-timeframe signal analysis to guide traders. The analysis emphasizes an exceptional 72.5:1 risk-reward setup, targeting a 21.9% gain versus 0.3% risk.
Precision Trading with Apollo Medical Holdings Inc. (ASTH) Risk Zones
This report provides a detailed analysis of Apollo Medical Holdings Inc. (ASTH), highlighting divergent sentiment and a mid-channel oscillation pattern. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis, identifying support and resistance levels for various time horizons.
Astrana Health Inc (ASTH-Q) Stock Price and News
This article provides current stock price and news for Astrana Health Inc (ASTH-Q), listed on NASDAQ. It includes recent analyst ratings, news headlines concerning its AI-driven value-based care strategy, Q2 earnings, and comparisons with peers. The company profile identifies Astrana Health as a provider-centric, technology-powered healthcare company based in ALHAMBRA, Calif.
Precision Trading with Apollo Medical Holdings Inc. (ASTH) Risk Zones
This article analyzes Apollo Medical Holdings Inc. (ASTH) stock, highlighting a weak near and mid-term sentiment despite a positive long-term outlook. It presents three AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis emphasizes an exceptional 81.4:1 risk-reward setup targeting a 22.4% gain versus 0.3% risk.
Apollo Medical Holdings Inc (3AM.MU) Stock Price, News, Quote & History
This article provides detailed financial information for Apollo Medical Holdings Inc (3AM.MU) including its stock price, historical data, and key performance metrics. It shows the stock trading at 30.40 EUR with a 0.00% change and outlines its YTD, 1-year, 3-year, and 5-year returns compared to the S&P 500. The page also offers various financial statistics, valuation measures, and company insights.
How Apollo Medical Holdings Inc. (ASTH) Affects Rotational Strategy Timing
This article analyzes Apollo Medical Holdings Inc. (ASTH) and its impact on rotational strategy timing, based on AI-generated signals. It highlights neutral near and mid-term readings, a positive long-term bias, and an exceptional risk-reward short setup. The analysis provides specific institutional trading strategies including position, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis.
Trading Systems Reacting to (ASTH) Volatility
Apollo Medical Holdings Inc. (NASDAQ: ASTH) is exhibiting a mid-channel oscillation pattern with positive near-term sentiment. AI models have generated three trading strategies: a Long Position Trading Strategy targeting a 22.9% gain, a Momentum Breakout Strategy, and a Risk Hedging Strategy, all with sophisticated risk management. The analysis highlights strong support and resistance signals across near-term and long-term time horizons.
How Apollo Medical Holdings Inc. (ASTH) Affects Rotational Strategy Timing
Apollo Medical Holdings Inc. (ASTH) shows weak near and mid-term sentiment but a strong long-term outlook, with AI models identifying a significant risk-reward short setup. The analysis provides specific trading strategies—Position, Momentum Breakout, and Risk Hedging—with defined entry points, targets, and stop losses. Multi-timeframe signal analysis highlights resistance and support levels to guide investor decisions.
How Apollo Medical Holdings Inc. (ASTH) Affects Rotational Strategy Timing
This article analyzes how Apollo Medical Holdings Inc. (ASTH) affects rotational strategy timing, highlighting weak near and mid-term sentiment despite a positive long-term outlook. It presents three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss zones. The analysis also includes a multi-timeframe signal breakdown for different holding periods.
(ASTH) and the Role of Price-Sensitive Allocations
Apollo Medical Holdings Inc. (NASDAQ: ASTH) is showing weak near and mid-term sentiment, despite a strong long-term outlook. AI models have generated three distinct trading strategies for ASTH: a long position trade, a momentum breakout, and a risk-hedging short. The analysis highlights key support and resistance levels across different time horizons, with a notable mid-channel oscillation pattern and a significant risk-reward short setup.
2 Reasons to Like ASTH and 1 to Stay Skeptical
Astrana Health (NASDAQ:ASTH), formerly Apollo Medical Holdings, has seen its stock price jump 79% in the last six months due to solid quarterly results. The company exhibits strong momentum with an annualized revenue growth of 38.3% and an impressive EPS growth of 13.2% over the past five years. However, a significant decline in its Return on Invested Capital (ROIC) raises a note of caution about its recent investments.
2 Reasons to Like ASTH and 1 to Stay Skeptical
Astrana Health (ASTH) has seen its stock price jump significantly, driven by strong financial performance. The company boasts impressive five-year annualized revenue growth of 38.3% and EPS growth of 13.2%. However, investors should be cautious as its Return on Invested Capital (ROIC) has declined, raising questions about the profitability of recent investments.
(ASTH) and the Role of Price-Sensitive Allocations
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH) using AI models to provide institutional trading strategies. It identifies weak near-term sentiment but strong mid and long-term outlooks, with compelling upside potential due to an absence of resistance levels above the current price. The analysis includes position trading, momentum breakout, and risk hedging strategies, along with multi-timeframe signal analysis for support and resistance levels.
(ASTH) and the Role of Price-Sensitive Allocations
This article provides an in-depth analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), focusing on its near-term sentiment, price positioning, and institutional trading strategies generated by AI models. It outlines specific long, breakout, and risk hedging strategies, along with multi-timeframe signal analysis for different holding periods. The report also highlights support and resistance levels for ASTH.
Responsive Playbooks and the ASTH Inflection
This article provides an in-depth analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting strong sentiment across all time horizons and compelling upside potential due to the absence of resistance levels above the current price. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis. The piece emphasizes institutional-grade analysis, real-time entry/exit signals, and risk management parameters.
Responsive Playbooks and the ASTH Inflection
This article provides an in-depth AI-driven analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting strong sentiment across all time horizons. It outlines distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also details multi-timeframe signal strengths and support/resistance levels for near-term, mid-term, and long-term outlooks.
Understanding the Setup: (ASTH) and Scalable Risk
This article provides an analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), indicating a neutral sentiment in the near and mid-term but a long-term positive bias. It details AI-generated trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis for various risk profiles. The report highlights potential upside due to no clear resistance levels above the current price.
The Technical Signals Behind (ASTH) That Institutions Follow
This article provides a technical analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH) for institutional investors. It highlights a neutral near-term sentiment but suggests potential for a sustained breakout to higher levels due to the absence of overhead resistance. The analysis also details three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis.
Precision Trading with Apollo Medical Holdings Inc. (ASTH) Risk Zones
This article provides a detailed analysis of Apollo Medical Holdings Inc. (ASTH) stock, highlighting conflicting sentiment across different time horizons and a lack of clear price positioning signals. It outlines specific institutional trading strategies, including long, breakout, and short positions, based on AI-generated signals with defined entry zones, targets, and stop losses. The analysis also presents multi-timeframe signal data indicating support and resistance levels for near-term, mid-term, and long-term trading.
Precision Trading with Apollo Medical Holdings Inc. (ASTH) Risk Zones
This article from Stock Traders Daily provides a detailed AI-generated analysis for Apollo Medical Holdings Inc. (ASTH), identifying conflicting sentiment across horizons and a lack of resistance levels above the current price, suggesting upside potential. It outlines three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis, including support and resistance levels for various holding periods. The report highlights key findings and offers institutional-grade analysis for precision trading.
Technical Reactions to ASTH Trends in Macro Strategies
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH) using AI models, identifying prevailing positive sentiment in the near and mid-term but elevated downside risk in the long term. It presents three trading strategies for different risk profiles: Position Trading, Momentum Breakout, and Risk Hedging, along with multi-timeframe signal analysis. The analysis highlights current support and resistance levels for various time horizons.
Technical Reactions to ASTH Trends in Macro Strategies
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH) using AI models, identifying strong near- and mid-term sentiment but elevated downside risk. It provides three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis to guide investors. The report emphasizes the importance of current signals for positioning and risk parameters.
Astrana Health (NASDAQ:ASTH) Beats Q1 CY2026 Sales Expectations
Astrana Health (NASDAQ:ASTH) reported strong Q1 CY2026 results, surpassing market expectations for revenue and adjusted EPS, with sales up 55.6% year-on-year to $965.1 million. The company reconfirmed its full-year revenue guidance of $3.95 billion but its EBITDA guidance fell slightly below analyst estimates. Despite impressive growth, the stock traded down 4.8% after the announcement, indicating the market may have hoped for even more.
Trading the Move, Not the Narrative: (ASTH) Edition
This article provides an AI-generated analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), focusing on trading strategies and risk management. It identifies strong near and mid-term sentiment, but notes elevated downside risk, offering specific long, breakout, and short trading strategies with entry zones, targets, and stop losses. The analysis also includes multi-timeframe signal analysis for support and resistance levels.
Apollo Medical Holdings Announced That It Will Formally Change Its Name From Apollo Medical Holdings, Inc. To Astrana Health, Inc. And Will Begin Trading Under The Ticker Symbol "ASTH", Both Effective February 26, 2024
Apollo Medical Holdings, Inc. announced that it will officially change its name to Astrana Health, Inc. This change will be effective on February 26, 2024, at which point the company will also begin trading under the new ticker symbol "ASTH". The insight is provided by Quantisnow, a market data and news platform for retail investors.
(ASTH) Volatility Zones as Tactical Triggers
This article from Stock Traders Daily analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting strong near and mid-term sentiment but a weak long-term outlook with elevated downside risk. It provides AI-generated tactical trading strategies including position, momentum breakout, and risk hedging, along with multi-timeframe signal analysis, including support and resistance levels. The analysis emphasizes current positive sentiment but warns of potential shifts.
Price-Driven Insight from (ASTH) for Rule-Based Strategy
This article provides a price-driven insight into Apollo Medical Holdings Inc. (NASDAQ: ASTH) for rule-based trading strategies, highlighting strong near- and mid-term sentiment but a weak long-term outlook. It presents AI-generated signals and three distinct institutional trading strategies for different risk profiles. The analysis points to elevated downside risk due to a lack of additional long-term support signals.
(ASTH) Price Dynamics and Execution-Aware Positioning
This article analyzes Apollo Medical Holdings Inc. (NASDAQ: ASTH) using AI models to provide trading strategies. It highlights a positive near-term sentiment that may shift, a mid-channel oscillation pattern, and an exceptional risk-reward setup targeting a 20.0% gain. Three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—are detailed, along with multi-timeframe signal analysis for different horizons.
A Look At Astrana Health (ASTH) Valuation After Rebrand And Mixed Shareholder Returns
Astrana Health (ASTH), formerly Apollo Medical Holdings, is drawing attention after its rebranding, despite mixed shareholder returns with a 20.65% 30-day gain contrasted by a 20.36% one-year decline. Analysts view the company as potentially undervalued, with a fair value estimate of $35.67 against a current price of $23.25, while also highlighting risks related to Medicare/Medicaid reliance and execution challenges for full-risk contracts. Investors are encouraged to assess the company's valuation, considering both its discounted price target and its high P/E ratio.
(ASTH) Risk Channels and Responsive Allocation
This article provides an in-depth analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH) based on AI models from Stock Traders Daily. It highlights near-term weak sentiment, exceptional risk-reward setups, and outlines three distinct trading strategies: Position Trading, Momentum Breakout, and Risk Hedging. The analysis includes multi-timeframe signal data and emphasizes real-time institutional-grade signals for risk management and optimized position sizing.
Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award from Healthgrades
Foothill Regional Medical Center, a part of Astrana Health, Inc., has been awarded the 2026 Patient Safety Excellence Award from Healthgrades, marking its fourth consecutive year receiving this recognition. This places the medical center among the top 5% in the nation for patient safety. The hospital also earned other distinguished Healthgrades awards for joint replacement and treatment of sepsis, highlighting its commitment to patient outcomes and quality care.
Astrana Health Inc. (ASTH) Investor Outlook: Analyst Ratings Suggest a 45% Upside Potential
Astrana Health Inc. (ASTH) is drawing investor attention with analyst ratings pointing to a potential 45% upside, largely driven by strong revenue growth and a strategic focus on reinvestment. The company, operating in the Medical Care Facilities industry, serves diverse patient populations and recently rebranded from Apollo Medical Holdings to emphasize its commitment to innovative care. Despite a slight recent dip in stock price, valuation metrics and positive technical indicators suggest a compelling opportunity for investors in the healthcare management sector.
Astrana Health (NASDAQ:ASTH) Beats Q4 CY2025 Sales Expectations
Astrana Health (NASDAQ:ASTH) exceeded Q4 CY2025 sales expectations with revenue up 42.9% year-on-year to $950.5 million, beating analyst estimates. While GAAP EPS was in line, the company's EBITDA guidance for the upcoming financial year 2026 was slightly below analyst estimates. Despite impressive revenue growth, the company has faced challenges with declining EPS and operating margins over the past five years, though its operating margin saw an increase in Q4.
Astrana Health Q4 2025 Earnings: Revenue Exceeds Expectations, 2026 Guidance - News and Statistics
Astrana Health (formerly Apollo Medical Holdings) reported Q4 2025 earnings, exceeding revenue expectations with $950.5 million. While GAAP EPS matched forecasts, the company's adjusted EBITDA outlook for the full 2026 financial year is slightly below current market expectations. The healthcare services company, which operates a technology-powered platform for physician-led care, has shown significant sales growth over the past five years.
Astrana Health (NASDAQ:ASTH) Beats Q4 CY2025 Sales Expectations
Astrana Health (NASDAQ:ASTH) reported strong Q4 CY2025 results, exceeding Wall Street's revenue expectations with sales of $950.5 million, a 42.9% year-on-year increase. The company's GAAP EPS was in line with estimates, and management provided optimistic EBITDA guidance for the upcoming financial year, although revenue guidance for Q1 CY2026 was in line with analyst estimates. Astrana Health's stock reacted positively to the earnings call, trading up 3.9% immediately after the announcement.
Astrana Health (NASDAQ:ASTH) Beats Q4 CY2025 Sales Expectations
Astrana Health (NASDAQ:ASTH) reported strong Q4 CY2025 results, with sales growing 42.9% year-on-year to $950.5 million, exceeding Wall Street expectations. While revenue guidance for Q1 CY2026 is in line with estimates, the company's full-year 2026 EBITDA guidance of $265 million is slightly below analyst predictions. The company highlighted record revenue, adjusted EBITDA, and free cash flow for 2025, attributing success to its value-based care model and AI-enabled technology.
(ASTH) Movement as an Input in Quant Signal Sets
This article provides a quantitative analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), highlighting its current stock movement as an input for quant signal sets. It identifies a strong near-term sentiment that could challenge persistent mid and long-term weakness, outlining specific institutional trading strategies including position trading, momentum breakout, and risk hedging with associated entry, target, and stop-loss levels. The report also details multi-timeframe signal analysis and support/resistance levels generated by AI models.
Will Anticipated Strong Earnings and Guidance Shift Astrana Health's (ASTH) Value‑Based Care Narrative?
Astrana Health (ASTH), formerly Apollo Medical Holdings, is anticipated to release strong earnings on March 2, 2026, with analysts expecting $0.26 EPS. The company has shown significant two-year annual revenue growth and a positive outlook in value-based care. The upcoming earnings report will be crucial in determining if Astrana can translate its strong revenue growth into durable profitability, given its exposure to government programs and prior profit compression.
Liquidity Mapping Around (ASTH) Price Events
This article provides an AI-generated analysis of Apollo Medical Holdings Inc. (NASDAQ: ASTH), indicating weak sentiment across all horizons and supporting a short bias. It details an exceptional 74.5:1 risk-reward setup targeting a 22.7% gain versus 0.3% risk. The report offers three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored to different risk profiles.
2 Reasons to Like ASTH (and 1 Not So Much)
Astrana Health (ASTH) has seen its stock price decline significantly, leading investors to question its potential. The company shows strong momentum with skyrocketing revenue growth and remarkable projected revenue growth from analysts, indicating its offerings resonate with customers and the market sees success for its products. However, a declining return on invested capital (ROIC) raises concerns about the effectiveness of its new investments, suggesting caution is warranted despite its potential.